Bill > HB1217

Introduced Session

AN ACT concerning Maryland Medical Assistance Program and Health Insurance - Required Coverage for Biomarker Testing FOR the purpose of requiring the Maryland Medical Assistance Program and certain insurers, nonprofit health service plans, health maintenance organizations, and managed care organizations to provide coverage for biomarker testing that is supported by medical and scientific evidence; establishing requirements for deductibles, copayments, coinsurance, and utilization review for biomarker testing; and generally relating to the coverage of biomarker testing by the Maryland Medical Assistance Program and health insurance carriers. BY adding to Article - Health - General Section 15-102.3(k) and 15-103(a)(2)(xxii) Annotated Code of Maryland (2019 Replacement Volume and 2022 Supplement) BY repealing and reenacting, without amendments, Article - Health - General Section 15-103(a)(1) Annotated Code of Maryland (2019 Replacement Volume and 2022 Supplement) BY repealing and reenacting, with amendments, Article - Health - General Section 15-103(a)(2)(xx) and (xxi) Annotated Code of Maryland (2019 Replacement Volume and 2022 Supplement) BY adding to Article - Insurance Section 15-859 Annotated Code of Maryland (2017 Replacement Volume and 2022 Supplement)

AI Summary

Committee Categories

Karen Toles (D)*,  Tiffany Alston (D),  Heather Bagnall (D),  Harry Bhandari (D),  Brian Chisholm (R),  Bonnie Cullison (D),  Pamela Guzzone (D),  Terri Hill (D),  Tom Hutchinson (R),  Steve Johnson (D),  Anne Kaiser (D),  Ken Kerr (D),  Nic Kipke (R),  Robbyn Lewis (D),  Lesley Lopez (D),  Ashanti Martínez (D),  Matt Morgan (R),  Joseline Peña-Melnyk (D),  Teresa Reilly (R),  Sandy Rosenberg (D),  Sheree Sample-Hughes (D),  Kathy Szeliga (R),  Deni Taveras (D),  Jennifer White Holland (D),  Jheanelle Wilkins (D),  Jamila Woods (D), 

Approved by the Governor - Chapter 323 (on 05/03/2023)

Official Document